Sansanima

Sansanima

Developing in vitro, cell-based assay technologies for the replacement of animal testing in the manufacture of clostridial neurotoxin-based medical products.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round
*

N/A

Early VC
Total Funding000k
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads